BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8272722)

  • 21. [New therapeutic approaches in type II diabetes].
    Reach G
    Journ Annu Diabetol Hotel Dieu; 1993; ():155-60. PubMed ID: 8331862
    [No Abstract]   [Full Text] [Related]  

  • 22. [Different clinical patterns of secondary drug failure in diabetes mellitus type II patients and their significance for diagnosis of secondary sulfonamide resistance].
    Gendeleka GF
    Lik Sprava; 2001; (3):158-9. PubMed ID: 11560011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences.
    Singh AK; Singh R
    Expert Rev Clin Pharmacol; 2016; 9(3):409-18. PubMed ID: 26732230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal insulin in combination with oral hypoglycemic agents in the management of type 2 diabetes.
    Springer J
    Diabetes Educ; 2004; 30(1):68-70. PubMed ID: 14999895
    [No Abstract]   [Full Text] [Related]  

  • 25. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?].
    Halimi S
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):287-93. PubMed ID: 11452223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
    Standl E; Füchtenbusch M
    Diabetologia; 2003 Mar; 46 Suppl 1():M30-6. PubMed ID: 12652356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of insulin secretagogues in the treatment of type 2 diabetes].
    Radermecker RP
    Rev Med Liege; 2005; 60(5-6):402-8. PubMed ID: 16035301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Question over insulin as add-on therapy.
    Nurs Times; 2014 Jun 18-24; 110(25):4. PubMed ID: 25087387
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin treatment for type 2 diabetes: when to start, which to use.
    Hamaty M
    Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of rapid insulin secretion: revisited.
    Grodsky GM
    Diabetes Technol Ther; 1999; 1(3):259-60. PubMed ID: 11475271
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin analog initiation and titration.
    Hinnen D
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():12-6. PubMed ID: 19402255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Insulin secretion is increased depending on glucose.. Metabolism regulation in type 2 diabetes mellitus over five paths].
    MMW Fortschr Med; 2009 May; 151(19):50. PubMed ID: 19827447
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
    Desai A; Tandon N
    Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin and antidiabetic agents -- the old and the new.
    Golembiewski J
    J Perianesth Nurs; 2006 Apr; 21(2):131-4. PubMed ID: 16600835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Approach to diabetes therapy. 2. Selection and the use of oral antidiabetics. 2) Agents to correct insulin resistance].
    Kashiwagi A; Maegawa H
    Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1530-5. PubMed ID: 11062900
    [No Abstract]   [Full Text] [Related]  

  • 37. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 38. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q; Trovati M; Dani F; Caselle MT; Vitali S; Cavalot F; Rocca G; Cantino G; Mularoni E; Libertucci D
    Minerva Endocrinol; 1984; 9(2):241-5. PubMed ID: 6390138
    [No Abstract]   [Full Text] [Related]  

  • 39. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2.
    Pagkalos EM
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S100-1. PubMed ID: 21864738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of insulin to oral therapy in type 2 diabetes.
    Dağdelen S
    N Engl J Med; 2008 Mar; 358(11):1197; author reply 1198. PubMed ID: 18337612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.